Showing results 1 to 20 of 95
next >
| Preview | Issue Date | Title | Author(s) |
| 2019 | A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: protocol and statistical considerations. | Reutens, A.T.; Jandeleit-Dahm, K.; Thomas, M.; Bach, L.A.; Colman, P.G.; Davis, T.M.E.; D'Emden, M.; Ekinci, E.I.; Fulcher, G.; Hamblin, P.S.; Kotowicz, M.A.; MacIsaac, R.J.; Morbey, C.; Simmons, D.; Soldatos, G.; Wittert, G.; Wu, T.; Cooper, M.E.; Shaw, J.E. |
| 2016 | A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes | Wu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C. |
| 2016 | A whey/guar "preload" improves postprandial glycaemia and HbA(1c) in type 2 diabetes: a 12-week, single-blind, randomised and placebo controlled trial | Mignone, L.; Wu, T.; Phillips, L.; Bound, M.; Checklin, H.; Grivell, J.; Jones, K.; Clifton, P.; Horowitz, M.; Rayner, C.; 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD) (12 Sep 2016 - 16 Sep 2016 : Munich, GERMANY) |
| 2019 | A whey/guar “preload” improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: a 12-week, single-blind, randomized, placebo-controlled trial | Watson, L.E.; Phillips, L.K.; Wu, T.; Bound, M.J.; Checklin, H.L.; Grivell, J.; Jones, K.L.; Clifton, P.M.; Horowitz, M.; Rayner, C.K. |
| 2022 | Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric Emptying | Marathe, C.S.; Pham, H.; Wu, T.; Trahair, L.G.; Rigda, R.S.; Buttfield, M.D.M.; Hatzinikolas, S.; Lange, K.; Rayner, C.K.; Mari, A.; Horowitz, M.; Jones, K.L. |
| 2017 | Acute effects of lixisenatide on gastric emptying, glycaemia and 'postprandial' blood pressure responses to an oral glucose load in healthy subjects and type 2 diabetes | Jones, K.; Rigda, R.; Buttfield, M.; Hatzinikolas, S.; Pham, H.; Marathe, C.; Wu, T.; Lange, K.; Trahair, L.; Rayner, C.; Horowitz, M.; 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017) (11 Sep 2017 - 15 Sep 2017 : Lisbon, PORTUGAL) |
| 2017 | Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes | Thazhath, S.; Marathe, C.S.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.L.; Bound, M.J.; Rigda, R.S.; Horowitz, M.; Jones, K.L.; Rayner, C.K. |
| 2016 | Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial | Thazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C. |
| 2021 | An integrated microfluidic sensing system platform for dissecting insulin secretion and extracellular Ca²⁺ dynamics of pancreatic islets | Huang, W.; Zhao, J.; Nicholas, L.M.; Shallan, A.; Priest, C.; Rayner, C.K.; Ebendorff-Heidepriem, H.; Wu, T.; Annual Meeting of the European Association for the Study of Diabetes (EASD) (27 Sep 2021 - 1 Oct 2021 : Virtual) |
| 2013 | Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans | Wu, T.; Bound, M.; Standfield, S.; Bellon, M.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C. |
| 2018 | Augmented capacity for peripheral serotonin release in human obesity | Young, R.; Lumsden, A.; Martin, A.; Schober, G.; Pezos, N.; Thazhath, S.; Isaacs, N.; Cvijanovic, N.; Sun, E.; Wu, T.; Rayner, C.; Nguyen, Q.N.; Fontgalland, D.; Rabbitt, P.; Hollington, P.; Sposato, L.; Due, S.; Wattchow, D.; Liou, A.; Jackson, V.; et al. |
| 2016 | Bile acid profiles in diabetic (db/db) mice and their wild type littermates | Chen, C.; Hu, B.; Wu, T.; Zhang, Y.; Xu, Y.; Feng, Y.; Jiang, H. |
| 2020 | Bitter taste signalling modulates bile acid-induced PYY, but not GLP-1 secretion in healthy humans | Xie, C.; Wang, X.; Bound, M.J.; Young, R.L.; Jones, K.L.; Horowitz, M.; Rayner, C.K.; Wu, T.; 56th Annual Meeting of the European Association for the Study of Diabetes (EASD) (21 Sep 2020 - 25 Sep 2020 : Virtual Online) |
| 2017 | Blockade of glucagon-like peptide-1 receptors by exendin(9-39) attenuates the increase in heart rate during small intestinal glucose infusion in type 2 diabetes | Rayner, C.; Wu, T.; Horowitz, M.; Jones, K.; 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017) (11 Sep 2017 - 15 Sep 2017 : Lisbon, PORTUGAL) |
| 2017 | Brief report: Ramadan as a model of intermittent fasting: Effects on body composition, metabolic parameters, gut hormones and appetite in adults with and without type 2 diabetes mellitus | Alharbi, T.; Wong, J.; Markovic, T.; Yue, D.; Wu, T.; Brooks, B.; Hetherington, J.; Seimon, R.; Gibson, A.; Toth, K.; Silviera, S.; Sainsbury, A.; Little, T. |
| 2014 | Changes in meal composition and duration affect postprandial endothelial function in healthy humans | Thazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Jones, K.; Willoughby, S.; Horowitz, M.; Rayner, C. |
| 2015 | Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy males | Wu, T.; Thazhath, S.; Marathe, C.; Bound, M.; Jones, K.; Horowitz, M.; Rayner, C.; Sebastian Thazhath, S, |
| 2017 | Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males | Wu, T.; Rayner, C.; Watson, L.; Jones, K.; Horowitz, M.; Little, T. |
| 2020 | Comparative effects of intraduodenal glucose and fat infusion on blood pressure and heart rate in type 2 diabetes | Xie, C.; Wang, X.; Jones, K.L.; Horowitz, M.; Sun, Z.; Little, T.J.; Rayner, C.K.; Wu, T. |
| 2019 | Comparative effects of intraduodenal glucose and fat on blood pressure and heart rate in type 2 diabetes | Horowitz, M.; Xie, C.; Wang, X.; Bound, M.J.; Grivell, J.; Jones, K.L.; Little, T.; Rayner, C.K.; Wu, T.; 55th Annual Meeting of the European Association for the Study of Diabetes (EASD) (16 Sep 2019 - 20 Sep 2019 : Barcelona, SPAIN) |
